Clin2
NCT05606133Possibly a fitRecruiting

Test HPV DNA from blood to track cervical cancer risk

Cervical DysplasiaCervical Cancer

Part of Cancer, Women’s health & pregnancy clinical trials.

This study looks at a blood test that measures HPV DNA to help screen and monitor people with HPV-related cervical problems. If you have confirmed high-grade cervical changes or cervical cancer, the test may help doctors follow how your condition changes over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Be age 18 or older
  • Have a biopsy result confirming HPV-related high-grade cervical dysplasia or cervical cancer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05774561Recruiting
Using blood tests to monitor HPV-related cancer treatment

This study checks whether “liquid biopsies” (blood tests that look for cancer-related signals) can help monitor how HPV-related cancers respond to treatment. It may help doctors spot changes earlier during care.

Olomouc
NCT07214584Recruiting
Using blood and cervical tests to track cervical cancer treatment response

This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.

Gainesville, Florida
NCT04743674Recruiting
Blood and urine tests to track cervical cancer after treatment

This study tests whether DNA found in blood and urine can help detect cervical cancer and monitor it after treatment. If you’re newly diagnosed, these minimally invasive samples may help doctors follow your disease more easily over time.

Chapel Hill, North Carolina
NCT07782697Not yet recruiting
HPV blood test to predict cervical cancer return after surgery

This trial studies a blood test that looks for HPV DNA after cervical cancer surgery. The test may help doctors predict if the cancer might come back and decide if more treatment is needed.

Hefei
NCT04857528Recruiting
Testing HPV DNA in anal and cervical tumors

This trial checks whether tumor samples contain HPV DNA (genetic material from the HPV virus). The goal is to improve detection in anal and cervical cancers, especially in patients planning standard radiation treatment.

Chicago, Illinois
NCT06859151Not yet recruiting
Dna changes linked to cervical cancer risk

This study looks at how changes in DNA (called methylation) may be linked to a higher chance of developing cervical cancer. By studying blood and tissue samples from people with abnormal screening results, researchers hope to find better ways to predict risk and detect cervical cancer earlier.

Hear when a new Cervical Dysplasia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.